Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
Federal PolicySeptember 30, 2026

Commerce Defines Exemptions to New 100% Pharma Import Tariff

The 100% Section 232 tariff on patented pharmaceuticals and related pharmaceutical ingredients took full effect September 29 for companies not covered under the earlier July 31 implementation date. The Commerce Department's Bureau of Industry and Security has specified which specialty pharmaceutical products qualify for a 0% tariff rate and which countries are eligible for exemptions. Drug manufacturers, importers, and distributors must now determine whether their products fall under the exempt categories or face the full tariff. The distinction affects sourcing and pricing decisions across the pharmaceutical supply chain.

Why it mattersManufacturers and Medicaid pharmacy programs face potential drug cost and supply chain disruptions depending on how tariff exemptions apply to imported active ingredients and finished products.

Pharmacy

Read the full article at beckershospitalreview.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.